loading
Tilray Brands Inc stock is traded at $1.63, with a volume of 24.87M. It is up +2.52% in the last 24 hours and down -5.23% over the past month. Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol.
See More
Previous Close:
$1.59
Open:
$1.58
24h Volume:
24.87M
Relative Volume:
1.10
Market Cap:
$1.43B
Revenue:
$788.94M
Net Income/Loss:
$-244.98M
P/E Ratio:
-0.7212
EPS:
-2.26
Net Cash Flow:
$-60.15M
1W Performance:
-3.55%
1M Performance:
-5.23%
6M Performance:
-14.21%
1Y Performance:
-20.49%
1-Day Range:
Value
$1.55
$1.65
1-Week Range:
Value
$1.45
$1.71
52-Week Range:
Value
$1.45
$2.97

Tilray Brands Inc Stock (TLRY) Company Profile

Name
Name
Tilray Brands Inc
Name
Phone
519.322.8800
Name
Address
655 MADISON AVENUE, NEW YORK
Name
Employee
2,650
Name
Twitter
@tilray
Name
Next Earnings Date
2024-10-10
Name
Latest SEC Filings
Name
TLRY's Discussions on Twitter

Tilray Brands Inc Stock (TLRY) Upgrades & Downgrades

Date Action Analyst Rating Change
Nov-02-22 Initiated Bernstein Mkt Perform
Jul-29-22 Downgrade The Benchmark Company Hold → Sell
Mar-04-22 Upgrade Canaccord Genuity Hold → Buy
Nov-18-21 Initiated Barclays Underweight
Nov-01-21 Downgrade Cantor Fitzgerald Overweight → Neutral
Jun-11-21 Downgrade CIBC Sector Outperform → Neutral
Jun-03-21 Upgrade Cantor Fitzgerald Neutral → Overweight
May-11-21 Resumed Cowen Outperform
May-07-21 Resumed Jefferies Buy
May-06-21 Initiated Canaccord Genuity Buy
Apr-28-21 Resumed BofA Securities Buy
Feb-18-21 Downgrade Piper Sandler Overweight → Neutral
Feb-18-21 Downgrade The Benchmark Company Buy → Hold
Nov-16-20 Downgrade Jefferies Hold → Underperform
Nov-11-20 Downgrade Stifel Hold → Sell
Oct-01-20 Reiterated MKM Partners Neutral
Sep-21-20 Upgrade Jefferies Underperform → Hold
May-12-20 Reiterated The Benchmark Company Buy
Apr-16-20 Downgrade Jefferies Hold → Underperform
Apr-09-20 Downgrade Consumer Edge Research Overweight → Equal Weight
Feb-24-20 Downgrade Cowen Outperform → Market Perform
Jan-13-20 Initiated BofA/Merrill Neutral
Nov-13-19 Reiterated The Benchmark Company Buy
Nov-05-19 Initiated Cantor Fitzgerald Neutral
Oct-22-19 Reiterated Piper Jaffray Overweight
Sep-20-19 Initiated MKM Partners Neutral
Aug-14-19 Reiterated The Benchmark Company Buy
Jul-17-19 Initiated Ladenburg Thalmann Neutral
Jun-28-19 Initiated Consumer Edge Research Overweight
Jun-06-19 Initiated Stifel Hold
Jun-05-19 Initiated Oppenheimer Perform
May-15-19 Upgrade BMO Capital Markets Underperform → Market Perform
May-13-19 Initiated Alliance Global Partners Neutral
View All

Tilray Brands Inc Stock (TLRY) Latest News

pulisher
03:08 AM

Piper Sandler maintains Neutral rating on Tilray shares despite revenue miss - Investing.com India

03:08 AM
pulisher
Oct 11, 2024

Tilray Brands Inc. stock rises Friday, outperforms market - MarketWatch

Oct 11, 2024
pulisher
Oct 11, 2024

Earnings call: Tilray reports record Q1 revenue, strong beverage growth By Investing.com - Investing.com Australia

Oct 11, 2024
pulisher
Oct 11, 2024

Earnings call: Tilray reports record Q1 revenue, strong beverage growth By Investing.com - Investing.com UK

Oct 11, 2024
pulisher
Oct 11, 2024

Tilray Earnings: Alcohol Is Increasingly Important but Has Limited Synergy with Cannabis - Morningstar

Oct 11, 2024
pulisher
Oct 11, 2024

Tilray Brands, Inc. (NASDAQ:TLRY): Are Analysts Optimistic? - Simply Wall St

Oct 11, 2024
pulisher
Oct 11, 2024

Are Investors Undervaluing Tilray Brands, Inc. (NASDAQ:TLRY) By 28%? - Yahoo Finance

Oct 11, 2024
pulisher
Oct 11, 2024

Tilray Brands First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance

Oct 11, 2024
pulisher
Oct 11, 2024

Tilray CEO optimistic about cannabis legalization after election - Yahoo Finance

Oct 11, 2024
pulisher
Oct 11, 2024

Tilray Brands Inc (TLRY) Q1 2025 Earnings Call Highlights: Recor - GuruFocus.com

Oct 11, 2024
pulisher
Oct 11, 2024

Tilray Brands Inc (TLRY) Q1 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ... - Yahoo Finance

Oct 11, 2024
pulisher
Oct 11, 2024

Tilray Brands Inc (TLRY) Q1 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada

Oct 11, 2024
pulisher
Oct 10, 2024

Tilray CEO Irwin Simon: 2024 Election Likely To Drive U.S. Cannabis Legalization, No Matter Who Wins - MSN

Oct 10, 2024
pulisher
Oct 10, 2024

Tilray CEO Irwin Simon: 2024 Election Likely To Drive U.S. Cannabis Legalization, No Matter Who Wins - Benzinga

Oct 10, 2024
pulisher
Oct 10, 2024

Tilray Reports $200M Q1 Net Revenue, Up 13% YoY As Net Loss Improves - MSN

Oct 10, 2024
pulisher
Oct 10, 2024

AMD's new AI chip, Tilray Brands CEO on earnings: Market Domination - Yahoo Finance

Oct 10, 2024
pulisher
Oct 10, 2024

Tilray Brands Inc. stock falls Thursday, underperforms market - MarketWatch

Oct 10, 2024
pulisher
Oct 10, 2024

Tilray’s adult-use cannabis and international revenue down year-over-year - StratCann

Oct 10, 2024
pulisher
Oct 10, 2024

Tilray is more than just a cannabis company, CEO explains why - Yahoo Finance

Oct 10, 2024
pulisher
Oct 10, 2024

Tilray CEO ‘optimistic’ about U.S. cannabis legalization ahead of election - BNN Bloomberg

Oct 10, 2024
pulisher
Oct 10, 2024

Tilray Brands considers US brewery consolidation - just-drinks.com

Oct 10, 2024
pulisher
Oct 10, 2024

Tilray CEO Bullish on Cannabis Legalization Following 2024 Election - Yahoo Finance

Oct 10, 2024
pulisher
Oct 10, 2024

Tilray Brands (TLRY) Q1 2025 Earnings Call Transcript - Yahoo! Voices

Oct 10, 2024
pulisher
Oct 10, 2024

Tilray Brands (TLRY) Q1 2025 Earnings Call Transcript - Nasdaq

Oct 10, 2024
pulisher
Oct 10, 2024

Tilray Brands considers US brewery consolidation - Yahoo Finance

Oct 10, 2024
pulisher
Oct 10, 2024

Tilray brands CEO on alcoholic beverage strategy - BNN Bloomberg

Oct 10, 2024
pulisher
Oct 10, 2024

Tilray Brands (TLRY) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates - MSN

Oct 10, 2024
pulisher
Oct 10, 2024

Tilray shows upward momentum with Q1 2025 results | 2024-10-10 | Investing News - Stockhouse Publishing

Oct 10, 2024
pulisher
Oct 10, 2024

Tilray Brands (TSE:TLRY) Shares Down 5.8%Time to Sell? - MarketBeat

Oct 10, 2024
pulisher
Oct 10, 2024

Tilray stock touches 52-week low at $1.47 amidst market challenges - Investing.com Canada

Oct 10, 2024
pulisher
Oct 10, 2024

Tilray Reports $200M Q1 Net Revenue, Up 13% YoY As Net Loss Improves - Benzinga

Oct 10, 2024
pulisher
Oct 10, 2024

Tilray Brands Shares Fall on 1Q Revenue Miss as Cannabis Sales Decline - MarketWatch

Oct 10, 2024
pulisher
Oct 10, 2024

TLRY Earnings: Tilray Brands Plummets as Q1 Revenues Fall Short of Estimates - TipRanks

Oct 10, 2024
pulisher
Oct 10, 2024

Tilray stock touches 52-week low at $1.47 amidst market challenges - Investing.com

Oct 10, 2024
pulisher
Oct 10, 2024

Tilray Brands reports US$34.7M first-quarter loss, revenue up from year ago - Richmond News

Oct 10, 2024
pulisher
Oct 10, 2024

Tilray Brands (TLRY) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance

Oct 10, 2024
pulisher
Oct 10, 2024

Tilray Brands reports US$34.7M first-quarter loss, revenue up from year ago - MSN

Oct 10, 2024
pulisher
Oct 10, 2024

Tilray’s revenue falls from the fourth quarter - Green Market Report

Oct 10, 2024
pulisher
Oct 10, 2024

Tilray Brands Files Regulatory 8-K Form with SEC - TipRanks

Oct 10, 2024
pulisher
Oct 10, 2024

Cannabis company Tilray Brands reports US$34.7-million first-quarter loss, revenue up from year ago - The Globe and Mail

Oct 10, 2024
pulisher
Oct 10, 2024

Tilray Brands reports US$34.7M first-quarter loss, revenue up from year ago - Marketscreener.com

Oct 10, 2024
pulisher
Oct 10, 2024

Tilray Brands reports US$34.7M first-quarter loss, revenue up from year ago - ThoroldNews.com

Oct 10, 2024
pulisher
Oct 10, 2024

Tilray Brands reports US$34.7M first-quarter loss, revenue up from year ago - Hamilton Spectator

Oct 10, 2024
pulisher
Oct 10, 2024

Tilray Brands’ Q1 2025 Net Revenue Surges by 13%, Reaching $200 Million - The Tokenist

Oct 10, 2024
pulisher
Oct 10, 2024

Don’t Dread Tilray’s Weakness - New Cannabis Ventures

Oct 10, 2024
pulisher
Oct 10, 2024

Tilray Brands, Inc. (TLRY) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance

Oct 10, 2024
pulisher
Oct 10, 2024

Tilray posts mixed Q1 results, gross profit up 35% YoY By Investing.com - Investing.com Australia

Oct 10, 2024
pulisher
Oct 10, 2024

Tilray Brands Fiscal 1Q Loss Narrows as Alcohol Beverages Drive Revenue Growth - MarketWatch

Oct 10, 2024
pulisher
Oct 10, 2024

Tilray stock gains after earnings report, and upbeat outlook on cannabis legalization - MSN

Oct 10, 2024
pulisher
Oct 10, 2024

Tilray stock gains after Q1 earnings beat (NASDAQ:TLRY) - Seeking Alpha

Oct 10, 2024
pulisher
Oct 10, 2024

Tilray posts mixed Q1 results, gross profit up 35% YoY - Investing.com

Oct 10, 2024

Tilray Brands Inc Stock (TLRY) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Tilray Brands Inc Stock (TLRY) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Merton Carl A
Chief Financial Officer
Jul 31 '24
Option Exercise
2.03
93,926
190,670
703,412
Gendel Mitchell
Global General Counsel
Jul 31 '24
Option Exercise
2.03
93,926
190,670
468,218
FALTISCHEK DENISE M
Chief Strategy Officer
Jul 31 '24
Option Exercise
2.03
93,926
190,670
583,643
SIMON IRWIN D
President and CEO
Jul 26 '24
Option Exercise
1.83
98,194
179,695
2,985,109
Merton Carl A
Chief Financial Officer
Jul 26 '24
Option Exercise
1.83
12,166
22,264
615,102
Looney Thomas P.
Director
Jul 26 '24
Option Exercise
1.83
129,534
237,047
230,038
Hopkinson David G.
Director
Jul 26 '24
Option Exercise
1.83
129,534
237,047
211,185
Herhalt Johann Michael
Director
Jul 26 '24
Option Exercise
1.83
129,534
237,047
180,514
Gendel Mitchell
Global General Counsel
Jul 26 '24
Option Exercise
1.83
12,166
22,264
380,504
FALTISCHEK DENISE M
Chief Strategy Officer
Jul 26 '24
Option Exercise
1.83
12,166
22,264
495,929
$112.19
price up icon 3.72%
$75.76
price up icon 2.92%
$60.45
price down icon 0.43%
$115.49
price up icon 2.74%
drug_manufacturers_specialty_generic RDY
$78.25
price up icon 1.28%
$11.38
price up icon 0.44%
Cap:     |  Volume (24h):